Our Focus

Unifying ExpertiseUnifying Expertise

interdisciplinary teams that share common interests to facilitate exchange of ideas and development of sustainable relationships

Innovative PartnershipsInnovative Partnerships

50 organisations and over 500 doctors, scientists, industry partners and policymakers locally and globally, including on innovative studies

Developing ExpertiseDeveloping Expertise

Hosting meetings and workshops to promote respiratory research, and educate and train junior clinician scientists, researchers and others

Prevention as a Focus

 

 

Improving The Lung Health Of Asian Populations

•Tackling the knowledge gap of respiratory diseases in Asian populations,
since existing treatment guidelines are based on data from non-Asian populations.
•Examining how local and regional environmental factors impact lung health,
and how respiratory diseases develop in and affect Asians.

•Building a database of Asian-focused lung diseases, as part of our wider effort
to enable more effective prevention and treatment interventions for Asians.

 

 

TARIPHThe TARIPH Centre aims to improve the lung health of Asian patients. 

Our Impact

Advancing Respiratory Health And Disease Research And Breakthroughs

•We secured a $10 million NMRC grant to deliver a national translational research programme, to find better ways to treat Asian respiratory disease.
•Our Singapore Severe Asthma Registry is the first multi-centre, large-scale registry of severe asthma patients in Singapore.
•Our TARIPH Lung Patient Network is Singapore’s first panel of patient advocates to aid respiratory research and support patient-centred innovation.

 

TARIPHThe TARIPH Centre and Lung Patient Network was launched by DPM Heng Swee Keat on 20 September 2023.

What others say about TARIPH

​"I am happy to participate in and support this new initiative. Having TARIPH will provide a platform to help link appropriate LKCMedicine and NTU Singapore faculty and clinicians across Singapore, and establish centres of excellence with each other to promote collaborative efforts that focus on research in pulmonary health and disease. This will be good for Singapore, as we see an urgent need to focus on population health issues from a Respiratory lens."

A/Prof John Abisheganaden, Director and Senior Consultant, Health Services and Outcome Research, NHG

​"We learn. We grow. We advance. Together."

A/Prof Mariko Koh, Senior Consultant, Department of Respiratory & Critical Care Medicine, SGH

"Lung health is poised to be the next significant medical condition in this generatio​n, after cancer and card​iometabolic disease. The formation of TARIPH is timely, to position Singapore at the frontiers of research, advancing the science of respiratory diseases, and most importantly benefiting the patients that we care for."

A/Prof Augustine Tee, Deputy Chairman, Medical Board (Medical Disciplines), CGH

"I look forward to having close collaborations with the wider community through TARIPH as I think there is collective strength and synergy in the expertise and experiences brought about by the various groups and in​dividuals here."

A/Prof Chew Fook Tim Vice Dean (Faculty of Science), Department of Biological Sciences, NUS

​​"TARIPH will be the crucible for seamless integrative research between family physicians and pulmonologists to identify key factors that will successfully improve the pulmonary health of the population.”​

Adj A/Prof Tan Ngiap Chuan Director, Department of Research, SingHealth Polyclinics Vice-Chair (Research), SingHealth-Duke NUS Family Medicine Academic Clinical Programme